Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pietro Majno

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
Annals of Surgery|October 1, 2019
Minor Hepatectomies: Focusing a Blurred Picture: Analysis of the Outcome of 4471 Open Resections in Patients Without CirrhosisLuca Viganò, Guido Torzilli, Roberto Troisi, et al.
Eclinicalmedicine|May 9, 2024
Safety and feasibility of chemotherapy followed by liver transplantation for patients with definitely unresectable colorectal liver metastases: insights from the TransMet randomised clinical trialRené Adam, David Badrudin, Laurence Chiche, et al.
Lancet (London, England)|September 21, 2024
Liver transplantation plus chemotherapy versus chemotherapy alone in patients with permanently unresectable colorectal liver metastases (TransMet): results from a multicentre, open-label, prospective, randomised controlled trialRené Adam, Céline Piedvache, Laurence Chiche, et al.
The Lancet. Oncology|December 9, 2008
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysisVincenzo Mazzaferro, Josep M Llovet, Rosalba Miceli, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
Annals of Surgery|October 1, 2019
Minor Hepatectomies: Focusing a Blurred Picture: Analysis of the Outcome of 4471 Open Resections in Patients Without CirrhosisLuca Viganò, Guido Torzilli, Roberto Troisi, et al.
Eclinicalmedicine|May 9, 2024
Safety and feasibility of chemotherapy followed by liver transplantation for patients with definitely unresectable colorectal liver metastases: insights from the TransMet randomised clinical trialRené Adam, David Badrudin, Laurence Chiche, et al.
Lancet (London, England)|September 21, 2024
Liver transplantation plus chemotherapy versus chemotherapy alone in patients with permanently unresectable colorectal liver metastases (TransMet): results from a multicentre, open-label, prospective, randomised controlled trialRené Adam, Céline Piedvache, Laurence Chiche, et al.
The Lancet. Oncology|December 9, 2008
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysisVincenzo Mazzaferro, Josep M Llovet, Rosalba Miceli, et al.
Pageof 10